ECT2L anticorps (C-Term) (FITC)

N° du produit ABIN2257333

Détail du produit anti-ECT2L anticorps (FITC)

Antigène: ECT2L (Epithelial Cell Transforming Sequence 2 Oncogene-Like (ECT2L))

Épitope: AA 725-753, C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ECT2L est conjugé à/à la FITC

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Réactivité croisée: Humain

Réactivité croisée (Details): Calculated cross reactivity: Hu

Attributs du produit: ECT2L, CT (ECT2L, C6orf91, LFDH, Epithelial cell-transforming sequence 2 oncogene-like, Lung-specific F-box and DH domain-containing protein, Putative guanine nucleotide exchange factor LFDH) (FITC)

Purification: Purified by Protein A affinity chromatography.

Immunogène: KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 725-753 in the C-terminal region of human ECT2L, UniProt Accession #Q008S8

Isotype: IgG

Information d'application

Indications d'application: Optimal working conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Supplied as a liquid in PBS, pH 7.2.

Stock: -20 °C

Stockage commentaire: -20°C

Détails sur ECT2L

Antigène: ECT2L (Epithelial Cell Transforming Sequence 2 Oncogene-Like (ECT2L))

Autre désignation: ECT2L (ECT2L Produits)

NCBI Accession: NP_001181966, NP_001071174

UniProt: Q008S8